Diabetes, Type 1 Clinical Trial
Official title:
Study of Minimed 640G Insulin Pump With SmartGuard in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia
The main objective is to evaluate the efficacy of sensor augmented pump (SAP) therapy with
MiniMed 640G with SmartGuard activation in preventing hypoglycemia events in comparison
sensor augmented pump (SAP) therapy with Minimed 640G without SmartGuard activation in type 1
diabetic adults with an increased risk of hypoglycemia.
The study should show:
- A reduction in the number of severe hypoglycemia, fewer hypoglycemic events and a
reduction in the time spent in hypoglycemia six months in any group compared to
Baseline.
- A complete prevention of severe and not severe hypoglycemia in the pump group Minimed
640G + Enlite sensor with SmartGuard activation
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02601729 -
Reimbursement Study of Continuous Glucose Monitoring in Belgium
|
||
| Completed |
NCT01805414 -
Breakfast Nutrition and Inpatient Glycemia
|
N/A | |
| Terminated |
NCT00700622 -
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
|
Phase 3 | |
| Completed |
NCT00308737 -
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
|
Phase 3 | |
| Terminated |
NCT01350102 -
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
|
Phase 4 | |
| Withdrawn |
NCT03494010 -
Hybrid Closed-Loop Insulin Delivery System in Type 1 Diabetes Candidates for a Living Donor Kidney Transplant
|
||
| Completed |
NCT02214719 -
Edmonton Automated Sugar Intelligence - Intelligent Diabetes Management, EASI-IDM, App Program to Assist Diabetes Care
|
N/A |